Deracin cleared for use with Denagard for swine

299

Approval gives swine industry new choice for treatment of dysentery, enteritis and pneumonia.

Pharmgate Animal Health announces Deracin®, a generic (ANADA) alternative to Aureomycin®, has been approved by the Food and Drug Administration for use in combination with the antimicrobial Denagard® for swine. This combination of Deracin® (chlortetracycline) and Denagard® (tiamulin hydrogen fumarate) is approved for the treatment of swine dysentery, enteritis and pneumonia.

“The new combination of Deracin® and Denagard® provides an economical, easy-to-use tool to treat sick pigs,” says Colin Gray, president and CEO of Pharmgate Animal Health. “Deracin® gives producers and swine veterinarians a choice in chlortetracycline without the need to change treatment protocols or question how it will work.”

Deracin® is a broad-spectrum medicated feed article (MFA) that is effective against gram-positive and gram-negative organisms that cause diseases such as enteritis, pneumonia, ileitis, leptospirosis and jowl abscesses. Deracin® is readily absorbed via oral administration, so it quickly reaches effective blood and lung concentrations. It is a veterinary feed directive (VFD) drug to be used by or on the order of a licensed veterinarian.

Pharmgate’s pioneer NADA chlortetracycline product, Pennchlor®, continues to be approved for combination use with Denagard®. Like Deracin®, Pennchlor® is a broad-spectrum MFA and effective against gram-positive and gram-negative organisms. Pennchlor® is highly concentrated for reduced handling and delivers versatility with a wide range of approved combinations.

“Our diverse product portfolio demonstrates our ongoing commitment to provide the industry useful, effective, high-quality products,” says Gray. “Offering both products provides producers, veterinarians and feed mills chlortetracycline treatment options.”

Ask your veterinarian or feed manufacturer to choose Deracin®. Learn more and find bluebird labels at pharmgate.com.

Pharmgate Animal Health is headquartered in Wilmington, North Carolina, and provides innovative and high-quality products that help the livestock industry optimize animal health, efficiency and production. Pharmgate Animal Health celebrated its 10th anniversary in 2018. The company’s pharmaceutical production facilities are located in Omaha, Nebraska; vaccine research and manufacturing operations are based in St. Paul, Minnesota. To learn more about Pharmgate Animal Health, visit our website at Pharmgate.com.

LEAVE A REPLY

Please enter your comment!
Please enter your name here